Miach Orthopaedics
- Company typePrivate
- Founded2015
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Miach Orthopaedics firmographics
Firmographics- Name
- Miach Orthopaedics
- Legal name
- Miach Orthopaedics Inc.
- Website
- https://miachortho.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Miach Orthopaedics industry classification
Industry- Product category
- Orthopedic Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair) (HLAHAEAF)
Keywords
Where Miach Orthopaedics is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Miach Orthopaedics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations, Others
Revenue model
- BEAR Implant Device Sales: Miach Orthopaedics generates revenue through the sale of its BEAR Implant medical devices to hospitals, surgical centers, and orthopedic surgeons. The company sells directly to healthcare providers who perform ACL restoration procedures.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels9 records
Miach Orthopaedics product offering
Product offeringCore offering
Miach Orthopaedics designs, manufactures, and commercializes the BEAR (Bridge-Enhanced ACL Restoration) Implant, an FDA-approved medical device that enables torn anterior cruciate ligaments to heal naturally. The implant is combined with the patient's own blood to form a protective clot that allows the body to restore the native ACL, eliminating the need for graft-based reconstruction. The company also delivers surgeon training, rehabilitation protocols, and clinical evidence programs that support adoption of the device across the U.S.
Product overview
Miach Orthopaedics offers the BEAR (Bridge-Enhanced ACL Restoration) Implant as its core product, an FDA-approved medical device that enables torn anterior cruciate ligaments (ACLs) to heal naturally rather than requiring surgical reconstruction with graft tissue. The product portfolio includes the BEAR Implant itself, the BEAR Academy national educational course for surgeons, specialized rehabilitation protocols, and ongoing clinical trials (Bridge Registry, BEAR MOON, BEAR III, BEAR I & II) that generate clinical evidence. Medical education offerings include webinars and training programs for both orthopedic surgeons and physical therapists, creating an integrated ecosystem supporting the entire BEAR treatment pathway from surgery through rehabilitation.
Differentiator
Problem solved
Functional benefit
Brands
- BEAR Implant: Bridge-Enhanced ACL Restoration Implant - an FDA-approved medical device that enables torn ACLs to heal naturally rather than requiring reconstruction with graft tissue.
Products and services
- BEAR Implant (Bridge-Enhanced ACL Restoration) FDA-approved resorbable scaffold medical device that, when combined with the patient's own autologous blood, creates a protective environment allowing a torn ACL to heal naturally. Sold to hospitals, ambulatory surgical centers, and orthopedic surgery practices for use by orthopedic surgeons performing ACL restoration procedures.
- BEAR Academy Regional in-person training courses designed for sports medicine orthopedic surgeons to learn BEAR Implant surgical techniques, including hands-on procedure training and networking opportunities.
- Physical Therapist Training Program Continuing education courses for physical therapists on BEAR Implant rehabilitation protocols, offered through the AASPT Learning Center and PhysicalTherapy.com with live demonstrations and clinical insights.
Quantifiable outcome
- 5% ACL retear rate demonstrated in first 200 Bridge Registry patients at 2 years
- +4 more outcomes
Companies that use Miach Orthopaedics
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Miach Orthopaedics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Miach Orthopaedics partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights6 records
Miach Orthopaedics competitors and assessment
Company assessmentBroad incumbents
- Smith & Nephew: Global orthopedic sports medicine giant with a broad ACL reconstruction portfolio (including the REGENETEN bioinductive implant and graft-based systems). Direct investor in Miach and the most direct competitor in the U.S. sports medicine channel.
- Arthrex: Privately held orthopedic device leader and dominant sports medicine franchise with extensive ACL reconstruction instrument sets, grafts, and the InternalBrace augmentation technology. Competes head-to-head for surgeon preference and OR shelf space.
- Stryker: Major orthopedic and sports medicine medtech offering ACL reconstruction systems, BIOSURE anchors, and a growing biologics portfolio. Scales BEAR-type innovation across its global sales infrastructure.
- Zimmer Biomet: Orthopedic reconstruction leader with knee sports medicine and ligament reconstruction products. Competes in the same OR and surgeon accounts as Miach via established graft and fixation technologies.
- Conmed: Sports medicine-focused orthopedic company with ACL reconstruction and soft tissue fixation products. Direct competitor for arthroscopic ACL procedures in ambulatory surgery centers.
Direct peers
- RTI Surgical: Specialty surgical implant company marketing allograft tissue and sports medicine implants for ligament reconstruction. Direct competitor in providing biological alternatives to autograft ACL reconstruction.
- LifeNet Health: Non-profit tissue allograft provider offering ligament and tendon grafts for ACL reconstruction. Competes with BEAR by providing biological reconstruction alternatives to autograft harvest.
Emerging players
- Vericel: Commercial-stage sports medicine and orthobiologics company (MACI, Carticel) targeting cartilage and sports medicine repair. Comparable in commercial stage and physician call-point focus, though focused on cartilage versus ligament.
- Anika Therapeutics: Orthopedic regenerative medicine company with hyaluronic-acid-based joint and soft tissue therapies. Overlap in regenerative sports medicine and orthopedic surgeon channels.
- Embody: Emerging sports medicine company developing collagen-based bio-fabricated implants for tendon and ligament repair. Direct technological overlap with BEAR on biological, resorbable scaffolds for sports medicine applications.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights7 records
Customer concentration
Miach Orthopaedics social profiles
Digital presenceMiach Orthopaedics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Miach Orthopaedics leadership team
Management profileNumber of profiles
Profiles3 records
Miach Orthopaedics funding detail
Funding detailFunding overview
Funding rounds5 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Miach Orthopaedics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Miach Orthopaedics
What does Miach Orthopaedics do?
Miach Orthopaedics designs, manufactures, and commercializes the BEAR (Bridge-Enhanced ACL Restoration) Implant, an FDA-approved medical device that enables torn anterior cruciate ligaments to heal naturally. The implant is combined with the patient's own blood to form a protective clot that allows the body to restore the native ACL, eliminating the need for graft-based reconstruction. The company also delivers surgeon training, rehabilitation protocols, and clinical evidence programs that support adoption of the device across the U.S.
Is Miach Orthopaedics a public or private company?
Miach Orthopaedics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Miach Orthopaedics founded?
Miach Orthopaedics was founded in 2015. It employs 11 to 50 people.
Where is Miach Orthopaedics based?
Miach Orthopaedics is headquartered in Boston, United States, in the North America region.
How does Miach Orthopaedics make money?
One revenue line is on record: BEAR Implant Device Sales.
Who are Miach Orthopaedics's main competitors?
Broad incumbents on record are Smith & Nephew, Arthrex, Stryker, Zimmer Biomet and Conmed. Direct peers are RTI Surgical and LifeNet Health. Emerging players are Vericel, Anika Therapeutics and Embody.
Does Miach Orthopaedics have an API?
No public API is recorded for Miach Orthopaedics.
What industry is Miach Orthopaedics in?
Miach Orthopaedics's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAF, Sports Medicine & Soft Tissue Repair Implants (Anchors/Grafts/Meniscal Repair). Its NAICS code is 339113 and its SIC code is 3842.